Entries by Steve

Df Dent & Co Holding in Fastenal Co (FAST) Has Cut as Valuation Rose; Chemocentryx (CCXI) Shares Rose While Bvf Cut Holding by $67.90 Million

Bvf Inc decreased its stake in Chemocentryx Inc (CCXI) by 78.1% based on its latest 2019Q1 regulatory filing with the SEC. Bvf Inc sold 5.22 million shares as the company’s stock rose 15.42% with the market. The hedge fund held 1.46 million shares of the health care company at the end of 2019Q1, valued at […]

EPS for ChemoCentryx, Inc. (CCXI) Expected At $-0.21; Ubs Oconnor Trimmed Its Equity L (ELS) Position

Analysts expect ChemoCentryx, Inc. (NASDAQ:CCXI) to report $-0.21 EPS on August, 8.They anticipate $0.07 EPS change or 50.00% from last quarter’s $-0.14 EPS. After having $-0.23 EPS previously, ChemoCentryx, Inc.’s analysts see -8.70% EPS growth. The stock decreased 1.45% or $0.12 during the last trading session, reaching $8.16. About 238,941 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) […]

Principal Financial Group (PFG) Holder Old Republic International Has Trimmed Stake; Bvf Holding in Chemocentryx (CCXI) Lowered by $67.90 Million as Share Value Rose

Old Republic International Corp decreased its stake in Principal Financial Group (PFG) by 17.03% based on its latest 2019Q1 regulatory filing with the SEC. Old Republic International Corp sold 102,000 shares as the company’s stock rose 11.32% with the market. The institutional investor held 497,000 shares of the accident &health insurance company at the end […]

InflaRx N.V. (IFRX) Reaches $2.89 52-Week Low; Aqr Capital Management Raised Lancaster Colony (LANC) Holding By $5.97 Million

The stock of InflaRx N.V. (NASDAQ:IFRX) hit a new 52-week low and has $2.63 target or 9.00% below today’s $2.89 share price. The 8 months bearish chart indicates high risk for the $75.00 million company. The 1-year low was reported on Jul, 19 by Barchart.com. If the $2.63 price target is reached, the company will […]

United States Hidradenitis Suppurativa Market, 2014-2019 & 2024 – Pipeline, Epidemiology, Market Valuations, Drugs (Sales & Market Share), and Competitive Landscape – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US Hidradenitis Suppurativa Market and Competitive Landscape – 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights into Hidradenitis Suppurativa pipeline products, Hidradenitis Suppurativa epidemiology, Hidradenitis Suppurativa market valuations and forecast, Hidradenitis Suppurativa drugs sales and competitive landscape in the US. The research is classified into seven sections – […]

InflaRx N.V. (IFRX) Reaches $2.86 Low on Jul, 19; Credit Suisse Ag Decreased By $1.71 Million Its Weight Watchers Intl New (Call) (WTW) Stake

Credit Suisse Ag decreased Weight Watchers Intl Inc New (Call) (WTW) stake by 63.14% reported in 2019Q1 SEC filing. Credit Suisse Ag sold 85,650 shares as Weight Watchers Intl Inc New (Call) (WTW)’s stock 0.00%. The Credit Suisse Ag holds 50,000 shares with $1.01M value, down from 135,650 last quarter. Weight Watchers Intl Inc New […]

United States Hidradenitis Suppurativa Market, 2014-2019 & 2024 – Pipeline, Epidemiology, Market Valuations, Drugs (Sales & Market Share), and Competitive Landscape

DUBLIN–(BUSINESS WIRE)– The “US Hidradenitis Suppurativa Market and Competitive Landscape – 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights into Hidradenitis Suppurativa pipeline products, Hidradenitis Suppurativa epidemiology, Hidradenitis Suppurativa market valuations and forecast, Hidradenitis Suppurativa drugs sales and competitive landscape in the US. The research is classified into seven sections […]

Analysts See $-0.55 EPS for InflaRx N.V. (IFRX); Anchor Capital Advisors Has Lowered By $1.58 Million Its Boston Scientific (BSX) Holding

Anchor Capital Advisors Llc decreased Boston Scientific Corp (BSX) stake by 3.46% reported in 2019Q1 SEC filing. Anchor Capital Advisors Llc sold 41,534 shares as Boston Scientific Corp (BSX)’s stock declined 6.39%. The Anchor Capital Advisors Llc holds 1.16M shares with $44.48 million value, down from 1.20M last quarter. Boston Scientific Corp now has $59.36 […]